LOOK AT THIS IF YOU'RE INTERESTED IN:
Uncovering the evidence that a single dose of HPV vaccine provides high levels of protection against high-risk strains of HPV.
HOW YOU CAN USE THIS MATERIAL:
Country immunisation stakeholders can stay updated on the latest evidence regarding HPV vaccine dosage and learn from other countries’ experiences to determine the efficacy and immunogenicity of a single-dose regimen of HPV vaccines.
OVERVIEW:
Researchers have concluded that a single dose of HPV vaccine provides high levels of protection against high-risk strains of HPV, even several years after vaccination, and induces a robust immune response. Explore how a single-dose schedule could be an important tool to improve health equity and reduce disparities in HPV-related cancers, protecting all girls everywhere against this preventable disease, in this evidence brief.